Tag: Prescription Drugs
ASCO: Vorasidenib Improves Progression-Free Survival in Grade 2 IDH-Mutant Glioma
Significant improvement seen in progression-free survival and in time to next intervention for vorasidenib versus placebo
Capivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
Findings seen in patients with hormone receptor-positive advanced breast cancer with relapse, progression during aromatase inhibitor treatment
Higher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
Findings seen in patients with ischemic stroke without occlusion of large or medium-sized vessels, at least one moderately to severely weak limb
Medicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With...
Drug makers will also have to gather and keep data in a registry showing how the drugs are working in the real world
8.2 Percent of Adults Do Not Take Meds as Prescribed Due to Cost
Likelihood of not taking medication as prescribed due to cost increased for women versus men and for those with disabilities
Intranasal Ketamine Seems Effective for Refractory Chronic Migraine
49.1 percent reported intranasal ketamine as very effective; 35.5 percent report quality of life was much better
Dispensing Meds in Emergency Department Likely to Improve Adherence
Barriers to obtaining meds after emergency department visits include lack of access due to pharmacy hours, affordability, lack of understanding of importance
Upadacitinib Superior to Placebo in Moderate-to-Severe Crohn Disease
Superior response seen with upadacitinib induction and maintenance treatments
APA: Ketamine Noninferior to ECT for Treatment-Resistant Depression
Ketamine noninferior in terms of response to treatment; ECT linked to decrease in memory recall after treatment
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
Agency does not review compounded drugs for safety, effectiveness, or quality; compounded medications are not FDA-approved
